scholarly journals Characteristics, Mortality and Cardiovascular Events in Chronic Kidney Disease According To Previous Type 2 Diabetes Mellitus and/or Hypertension. A Population-Based Epidemiological Study (KIDNEES)

Author(s):  
Betlem Salvador-González ◽  
Oriol Cunillera-Puértolas ◽  
David Vizcaya ◽  
M Jesus Cerain-Herrero ◽  
Neus Gil-Terrón ◽  
...  

Abstract Introduction and objectives. Chronic Kidney Disease (CKD) entails a considerable burden of adverse outcomes. Identifying the cause is recommended but data on its prognostic value are scarce. We aimed to estimate how the clinical, cardiovascular events (CVE) and all-cause mortality (ACM) of CKD patients differs according to previous Type 2 Diabetes Mellitus (2TD) and/or Hypertension (HTN). Methods. We conducted a retrospective cohort study based on electronic health records of subjects aged 18–90 years old, with incident CKD between 1st January 2007 and 31st December 2017. The association between CKD groups according to previous T2D and/or HTN, and risk of ACM and CVE at follow-up were determined with Cox and Fine-Gray regressions, respectively. Results. 398,477 subjects were included. Median age was 74years, 55.2% were women. Individuals were distributed to HTN-CKD (51.9%), T2D-CKD (3.87%), HTN/T2D-CKD (31.4%) and unspecified-CKD (12.9%). In the multivariate analysis, with the T2D-CKD group as reference, the ACM Hazard Ratio (HR) was 0.645 (95%CI 0.624–0.667) in HTN-CKD, 0.704 (95%CI 0.682–0.728) in HTN/T2D-CKD and 0.875 (95%CI 0.844–0.908) in Unspecified-CKD group. The respective sub distribution HRs for CVE were 1.006 (CI95% 0.946–1.069), 1.238 (CI95% 1.164–1.316) and 0.722 (CI95% 0.665–0.785). Conclusion. In individuals with CKD, the risk of ACM and CVE differed according to previous HTN or/and T2D. These characteristics can help identifying individuals at higher risk of adverse outcomes, and improving the management of CKD patients in primary care.

Circulation ◽  
2018 ◽  
Vol 138 (25) ◽  
pp. 2908-2918 ◽  
Author(s):  
Johannes F. E. Mann ◽  
Vivian Fonseca ◽  
Ofri Mosenzon ◽  
Itamar Raz ◽  
Bryan Goldman ◽  
...  

2015 ◽  
Vol 35 (5) ◽  
pp. 487-492
Author(s):  
José Antonio Gimeno-Orna ◽  
Yolanda Blasco-Lamarca ◽  
Belén Campos-Gutierrez ◽  
Edmundo Molinero-Herguedas ◽  
Luis Miguel Lou-Arnal ◽  
...  

Author(s):  
Nóra Kovács ◽  
Attila Nagy ◽  
Viktor Dombrádi ◽  
Klára Bíró

The prevalence of type 2 diabetes mellitus (T2DM) and the burden of complications are increasing worldwide. Chronic kidney disease (CKD) is one serious complication. Our aim was to investigate the trends and inequalities of the burden of CKD due to T2DM between 1990 and 2019. Data were obtained from the Global Health Data Exchange database. Age-standardized incidence, mortality, and DALYs rates of CKD were used to estimate the disease burden across the Human Development Index (HDI). Joinpoint regression was performed to assess changes in trend, and the Gini coefficient was used to assess health inequality. A higher incidence was observed in more developed countries (p < 0.001), while higher mortality and DALYs rates were experienced in low and middle HDI countries in 2019 (p < 0.001). The trend of incidence has increased since 1990 (AAPC: 0.9–1.5%), while slight decrease was observed in low HDI countries in mortality (APC: −0.1%) and DALYs (APC: −0.2%). The Gini coefficients of CKD incidence decreased from 0.25 in 2006 to 0.23 in 2019. The socioeconomic development was associated with disease burden. Our findings indicate that awareness of complications should be improved in countries with high incidence, and cost-effective preventive, diagnostic, and therapeutic tools are necessary to implement in less developed regions.


Sign in / Sign up

Export Citation Format

Share Document